Michele Morari (M Morari)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 10

Top Topics

Parkinson Disease

Top Venues

British journal of pharmacology

Science advances

Biochemical Society transactions

This page only lists publications with an associated author ORCID identifier.

Publications

Chiara Domenicale, Daniela Mercatelli, Federica Albanese, Salvatore Novello, Fabrizio Vincenzi, Katia Varani, Michele Morari
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice. Biomedicines 10 (4) (2022)
Federica Albanese, Chiara Domenicale, Mattia Volta, Michele Morari
Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway. Biochemical Society transactions 50 (1) (2022)
Maria Regoni, Letizia Zanetti, Stefano Comai, Daniela Mercatelli, Salvatore Novello, Federica Albanese, Laura Croci, Gian Giacomo Consalez, Andrea Ciammola, Flavia Valtorta, Michele Morari, Jenny Sassone
Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse. Biomedicines 9 (5) (2021)
C A Pisanò, D Mercatelli, M Mazzocchi, A Brugnoli, I Morella, S Fasano, N T Zaveri, R Brambilla, G W O'Keeffe, R R Neubig, Michele Morari
RGS4 negatively modulates Nociceptin/Orphanin FQ opioid receptor signaling: implication for L-Dopa-induced dyskinesia. British journal of pharmacology (2021)
Daniela Mercatelli, Erwan Bezard, Roberto Eleopra, Nurulain T Zaveri, Michele Morari
Managing Parkinson's disease: moving ON with NOP. British journal of pharmacology 177 (1) (2020)
Mathieu Bourdenx, Aurélien Nioche, Sandra Dovero, Marie-Laure Arotcarena, S Camus, G Porras, Marie-Laure Thiolat, Nicolas P Rougier, Alice Prigent, P Aubert, Sylvain Bohic, Christophe Sandt, Florent Laferriere, E Doudnikoff, N Kruse, B Mollenhauer, Salvatore Novello, Michele Morari, Thierry Leste-Lasserre, I Trigo Damas, M Goillandeau, C Perier, C Estrada, N Garcia-Carrillo, Ariadna Recasens, Nishant N Vaikath, O M A El-Agnaf, M T Herrero, P Derkinderen, Miquel Vila, J A Obeso, Benjamin Dehay, Erwan Bezard
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates. Science advances 6 (20) (2020)
Sergio Vegas-Suárez, Clarissa Anna Pisanò, Catalina Requejo, Harkaitz Bengoetxea, José-Vicente Lafuente Sánchez, Michele Morari, Cristina Miguelez, Luisa Ugedo
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata. British journal of pharmacology 177 (17) (2020)
Daniela Mercatelli, Paolo Bolognesi, Martina Frassineti, Clarissa A Pisanò, Francesco Longo, Derya R Shimshek, Michele Morari
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes. Pharmacology research & perspectives 7 (3) (2019)
Ludovico Arcuri, Salvatore Novello, Martina Frassineti, Daniela Mercatelli, Clarissa Anna Pisanò, Ilaria Morella, Stefania Fasano, Blair V Journigan, Michael E Meyer, Willma E Polgar, Riccardo Brambilla, Nurulain T Zaveri, Michele Morari
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists. British journal of pharmacology 175 (5) (2018)
Francesco Longo, Daniela Mercatelli, Salvatore Novello, Ludovico Arcuri, Alberto Brugnoli, Fabrizio Vincenzi, Isabella Russo, Giulia Berti, Omar S Mabrouk, Robert T Kennedy, Derya R Shimshek, Katia Varani, Luigi Bubacco, Elisa Greggio, Michele Morari
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice. Acta neuropathologica communications 5 (1) (2017)